Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Concentration of revenue (Details)

v3.22.2.2
Significant Accounting Policies - Concentration of revenue (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Concentration Risk [Line Items]        
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor Successor Predecessor
Total Revenue $ 248,260,073 $ 156,185,955 $ 791,258,378 $ 452,070,338
Revenue | Customer Concentration        
Concentration Risk [Line Items]        
Total Revenue $ 248,260,073 $ 156,185,955 $ 791,258,378 $ 452,070,338
Percentage of total revenue 100.00% 100.00% 100.00% 100.00%
Health Plan A | Revenue | Customer Concentration        
Concentration Risk [Line Items]        
Total Revenue $ 35,936,246 $ 36,417,184 $ 124,681,687 $ 114,230,860
Percentage of total revenue 14.50% 23.30% 15.80% 25.30%
Health Plan B | Revenue | Customer Concentration        
Concentration Risk [Line Items]        
Total Revenue $ 46,082,052 $ 38,227,530 $ 139,920,223 $ 105,261,569
Percentage of total revenue 18.50% 24.50% 17.70% 23.30%
Health Plan C | Revenue | Customer Concentration        
Concentration Risk [Line Items]        
Total Revenue $ 48,538,454 $ 29,563,741 $ 158,252,527 $ 84,489,621
Percentage of total revenue 19.50% 18.90% 20.00% 18.70%
Health Plan D | Revenue | Customer Concentration        
Concentration Risk [Line Items]        
Total Revenue $ 31,563,532 $ 18,913,641 $ 104,439,689 $ 56,606,725
Percentage of total revenue 12.80% 12.10% 13.20% 12.50%
All Other | Revenue | Customer Concentration        
Concentration Risk [Line Items]        
Total Revenue $ 86,139,789 $ 33,063,859 $ 263,964,252 $ 91,481,563
Percentage of total revenue 34.70% 21.20% 33.30% 20.20%